For a better beginnings – breastfeading and baby matters by Lynne–McKensey Hall.
California Cryobank Stem Cell Services LLC (dba "FamilyCord"), announced the recent acquisition of LifeLine Cryogenics, an east coast cord blood and reproductive tissue bank primarily servicing the New York tristate area. LifeLine clients will maintain full access to their invaluable tissues, and all prepaid contracts will be honored. Since 1991, LifeLine has provided a broad spectrum of cryogenics services, offering storage of sperm, eggs, embryos, and cord blood stem cells. LifeLine Cryogenics was the first cord blood processing and storage facility in the Northeast. Medical director Gad Lavy M.D., F.A.C.O.G., is a nationally recognized leader in the reproductive marketplace and is also the founder of New England Fertility. "LifeLine's commitment to excellence and high scientific standards made for a seamless transition," says Richard Jennings, President of California Cryobank Stem Cell Services. "We worked closely with their team to ensure the quality and integrity of these valuable tissues was maintained. We are very pleased to continue providing high-quality cryogenic service to the LifeLine families for years to come." California Cryobank has been a leading cellular therapies company since 1977. Its subsidiary, FamilyCord, has been a global leader in cord blood and tissue services for more than 17 years. The company has an "A+" rating with the Better Business Bureau and is operated by nationally renowned physicians, including a stem cell transplant physician. FamilyCord is guided by world-class scientific expertise and medical ethics. California Cryobank and FamilyCord have extensive experience in clinical laboratory management, cord blood banking and frozen tissue storage. "People are more aware every day of the clinical benefits of cord blood and tissue stem cells," explains Jennings. "While our hope is that families will never need to use their umbilical stem cells, if that time should ever come, there is no substitute for scientifically superior collection, processing, and storage." FamilyCord's specially engineered cord blood and cord tissue collection kit is OSHA compliant and offers multiple benefits over traditional kits, including built-in temperature stabilization and a reinforced liner providing more than 4 times the standard crush protection. "As more and more families continue to take advantage of cord blood banking, it is imperative that we as an industry do everything we can to insure that investment is protected," says Jennings. Source: FamilyCord
During our pregnancy we learnt from our O&G that we could save our baby’s stem cells as a form of insurance in case our child ever suffered from an illness that required stem cell treatment – explaining that this is 100% match to our child & can currently be stored for 25 years. My partner and I would like to thank everyone at Stemlife from the start to the finish during this important decision to store our baby’s cord blood. Thank you to Kylie for co-ordinating & Marian our cord blood collector on the day. We are now expecting our 2nd child and have not hesitated to contact Stemlife again to begin the process to ensure all our children have their umbilical cord stem cells stored.
July 1, 2015 -- Scientists say they've accidentally found a possible treatment for eczema and rheumatoid arthritis. Their original research was focused on how to treat a condition called skin graft versus host disease (GvHD). It affects some people who get a stem cell transplant, through which you basically get a new immune system. GvHD is a side effect of the transplant process in which the person's new immune system attacks their body, often leading to severe skin reactions. So what do that condition, eczema, and RA have in common? They're all linked to inflammation and a haywire immune response. Ingredients in umbilical cord blood have properties that lower inflammation and suppress the immune system. But for a long time experts didn't know what these ingredients were. The scientists who made the new discovery were looking at whether certain proteins found in cord blood might have these properties. The proteins are called soluble NKG2D ligands. They disable natural "killer cells" the immune system uses to fight off things it sees as foreign to the body. So, they may prevent the mother and baby from rejecting each other. The scientists have also found that these proteins can be used to disable natural killer cells in other parts of the body. They think the discovery could eventually lead to the development of a cream containing cord blood proteins, which could ease the symptoms of eczema and rheumatoid arthritis, as well as of GvHD. A Big Breakthrough? "Currently, conditions such as eczema and rheumatoid arthritis are hard to manage, so this accidental discovery could potentially offer a major breakthrough," says Aurore Saudemont, PhD, senior research scientist at Anthony Nolan, a U.K.-based blood cancer charity. "As well as helping to treat blood cancer patients suffering with the effects of GvHD, these new findings could eventually lead to treatments that could eradicate symptoms of eczema, rheumatoid arthritis, and even alopecia areata without causing any major side effects. "This could be life-changing for patients, as their symptoms, such as inflammation, itching, and redness, can be a serious problem." The study is published in the European Journal of Immunology. Further research, and the involvement of a pharmaceutical company, is needed before a cream can be developed, but the scientists say they hope it could be tested on the first patients within 5 years. Article sources: S. Cox. European Journal of Immunology, July 2015. | Anthony Nolan.
Nature video presents: How do you make a working human heart? Scientists can turn stem cells into beating heart cells, but getting them to organize into a 3D heart requires a scaffold. In this video, Brendan Maher finds out how the technique could be used to develop parts of the heart, like the aortic root and valve, for transplant. Another group of scientists, next to Dr Doris Taylor and her team, is working on this exciting project and the question is - when first hearts will be ready? That is big news, considering the fact heart failure is number one reason of death in most countries worldwide. At the Massachusetts General Hospital in Boston, Harald Ott and his team are reusing the scaffold that nature provides. They're stripping away all the living cells from dead hearts, before filling in the leftover matrix with healthy new cells. Source
transplants have been performed using stem cells.
It seems like every day we can find a new advancement that science has made to use stem cells in healing and curing the human body. This story is about a little boy who was born with cerebral palsy. Clink the link to experience his story:http://ow.ly/qpR92
transplants have been performed using stem cells.